Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 228 entries
Sorted by: Best Match Show Resources per page
Learning conditions at work: a framework to understand and assess informal learning in the workplace

informal learning

Skule S.
GSID: O0m21FR4LoQJ
S Skule - International journal of training and development, 2004 - Wiley Online Library

… The framework consists of seven learning conditions, which have significant effects on informal learning at work. Implications for further … and benchmark learning, however, reveals a striking gap between this broad view of informal learning, and the types...

Cite
Skule, S. (2004). Learning conditions at work: a framework to understand and assess informal learning in the workplace. International journal of training and development, 8(1), 8-20.
Skule, Sveinung. "Learning conditions at work: a framework to understand and assess informal learning in the workplace." International journal of training and development 8.1 (2004): 8-20.
Copy Download .nbib Format: MLA
Higher discontinuation and lower survival rates are likely in elderly Japanese patients with advanced hepatocellular carcinoma receiving sorafenib.

Hepatology research : the official journal of the Japan Society of Hepatology

Morimoto M, Numata K, Kondo M, Hidaka H, Takada J, Shibuya A, Kobayashi S, Ohkawa S, Okuse C, Morita S, Taguri M, Tanaka K.
PMID: 21348907
Hepatol Res. 2011 Apr;41(4):296-302. doi: 10.1111/j.1872-034X.2011.00778.x. Epub 2011 Feb 23.

AIM:   Sorafenib is approved for the treatment of advanced hepatocellular carcinoma (HCC) in Japan; however, its tolerability and efficacy in elderly patients with HCC have not been clarified. We aimed to evaluate the tolerability and efficacy of sorafenib with...

Cite
Morimoto M, Numata K, Kondo M, et al. Higher discontinuation and lower survival rates are likely in elderly Japanese patients with advanced hepatocellular carcinoma receiving sorafenib. Hepatol Res. 2011;41(4):296-302doi: 10.1111/j.1872-034X.2011.00778.x.
Morimoto, M., Numata, K., Kondo, M., Hidaka, H., Takada, J., Shibuya, A., Kobayashi, S., Ohkawa, S., Okuse, C., Morita, S., Taguri, M., & Tanaka, K. (2011). Higher discontinuation and lower survival rates are likely in elderly Japanese patients with advanced hepatocellular carcinoma receiving sorafenib. Hepatology research : the official journal of the Japan Society of Hepatology, 41(4), 296-302. https://doi.org/10.1111/j.1872-034X.2011.00778.x
Morimoto, Manabu, et al. "Higher discontinuation and lower survival rates are likely in elderly Japanese patients with advanced hepatocellular carcinoma receiving sorafenib." Hepatology research : the official journal of the Japan Society of Hepatology vol. 41,4 (2011): 296-302. doi: https://doi.org/10.1111/j.1872-034X.2011.00778.x
Morimoto M, Numata K, Kondo M, Hidaka H, Takada J, Shibuya A, Kobayashi S, Ohkawa S, Okuse C, Morita S, Taguri M, Tanaka K. Higher discontinuation and lower survival rates are likely in elderly Japanese patients with advanced hepatocellular carcinoma receiving sorafenib. Hepatol Res. 2011 Apr;41(4):296-302. doi: 10.1111/j.1872-034X.2011.00778.x. Epub 2011 Feb 23. PMID: 21348907.
Copy Download .nbib Format: NLM
A nanoscale demonstration of hydrogen atom spillover and surface diffusion across silica using the kinetics of CO2 methanation catalyzed on spatially separate Pt and Co nanoparticles.

Nano letters

Beaumont SK, Alayoglu S, Specht C, Kruse N, Somorjai GA.
PMID: 25026434
Nano Lett. 2014 Aug 13;14(8):4792-6. doi: 10.1021/nl501969k. Epub 2014 Jul 17.

Hydrogen spillover is of great importance to understanding many phenomena in heterogeneous catalysis and has long been controversial. Here we exploit well-defined nanoparticles to demonstrate its occurrence through evaluation of CO2 methanation kinetics. Combining platinum and cobalt nanoparticles causes...

Cite
Beaumont SK, Alayoglu S, Specht C, et al. A nanoscale demonstration of hydrogen atom spillover and surface diffusion across silica using the kinetics of CO2 methanation catalyzed on spatially separate Pt and Co nanoparticles. Nano Lett. 2014;14(8):4792-6doi: 10.1021/nl501969k.
Beaumont, S. K., Alayoglu, S., Specht, C., Kruse, N., & Somorjai, G. A. (2014). A nanoscale demonstration of hydrogen atom spillover and surface diffusion across silica using the kinetics of CO2 methanation catalyzed on spatially separate Pt and Co nanoparticles. Nano letters, 14(8), 4792-6. https://doi.org/10.1021/nl501969k
Beaumont, Simon K, et al. "A nanoscale demonstration of hydrogen atom spillover and surface diffusion across silica using the kinetics of CO2 methanation catalyzed on spatially separate Pt and Co nanoparticles." Nano letters vol. 14,8 (2014): 4792-6. doi: https://doi.org/10.1021/nl501969k
Beaumont SK, Alayoglu S, Specht C, Kruse N, Somorjai GA. A nanoscale demonstration of hydrogen atom spillover and surface diffusion across silica using the kinetics of CO2 methanation catalyzed on spatially separate Pt and Co nanoparticles. Nano Lett. 2014 Aug 13;14(8):4792-6. doi: 10.1021/nl501969k. Epub 2014 Jul 17. PMID: 25026434.
Copy Download .nbib Format: NLM
Hydrocarbon chain lengthening in catalytic CO hydrogenation: evidence for a CO-insertion mechanism.

Journal of the American Chemical Society

Schweicher J, Bundhoo A, Kruse N.
PMID: 22992066
J Am Chem Soc. 2012 Oct 03;134(39):16135-8. doi: 10.1021/ja3068484. Epub 2012 Sep 21.

We studied CO hydrogenation over Co/MgO (10/1) model catalysts using chemical transient kinetics. Quantification of the time-dependent response during fast changes of the gas flow composition enabled the counting of surface amounts of carbon, oxygen, and hydrogen from the...

Cite
Schweicher J, Bundhoo A, Kruse N. Hydrocarbon chain lengthening in catalytic CO hydrogenation: evidence for a CO-insertion mechanism. J Am Chem Soc. 2012;134(39):16135-8doi: 10.1021/ja3068484.
Schweicher, J., Bundhoo, A., & Kruse, N. (2012). Hydrocarbon chain lengthening in catalytic CO hydrogenation: evidence for a CO-insertion mechanism. Journal of the American Chemical Society, 134(39), 16135-8. https://doi.org/10.1021/ja3068484
Schweicher, Julien, et al. "Hydrocarbon chain lengthening in catalytic CO hydrogenation: evidence for a CO-insertion mechanism." Journal of the American Chemical Society vol. 134,39 (2012): 16135-8. doi: https://doi.org/10.1021/ja3068484
Schweicher J, Bundhoo A, Kruse N. Hydrocarbon chain lengthening in catalytic CO hydrogenation: evidence for a CO-insertion mechanism. J Am Chem Soc. 2012 Oct 03;134(39):16135-8. doi: 10.1021/ja3068484. Epub 2012 Sep 21. PMID: 22992066.
Copy Download .nbib Format: NLM
A central support system can facilitate implementation and sustainability of a Classroom-based Undergraduate Research Experience (CURE) in Genomics.

CBE life sciences education

Lopatto D, Hauser C, Jones CJ, Paetkau D, Chandrasekaran V, Dunbar D, MacKinnon C, Stamm J, Alvarez C, Barnard D, Bedard JE, Bednarski AE, Bhalla S, Braverman JM, Burg M, Chung HM, DeJong RJ, DiAngelo JR, Du C, Eckdahl TT, Emerson J, Frary A, Frohlich D, Goodman AL, Gosser Y, Govind S, Haberman A, Hark AT, Hoogewerf A, Johnson D, Kadlec L, Kaehler M, Key SC, Kokan NP, Kopp OR, Kuleck GA, Lopilato J, Martinez-Cruzado JC, McNeil G, Mel S, Nagengast A, Overvoorde PJ, Parrish S, Preuss ML, Reed LD, Regisford EG, Revie D, Robic S, Roecklien-Canfield JA, Rosenwald AG, Rubin MR, Saville K, Schroeder S, Sharif KA, Shaw M, Skuse G, Smith CD, Smith M, Smith ST, Spana EP, Spratt M, Sreenivasan A, Thompson JS, Wawersik M, Wolyniak MJ, Youngblom J, Zhou L, Buhler J, Mardis E, Leung W, Shaffer CD, Threlfall J, Elgin SC.
PMID: 25452493
CBE Life Sci Educ. 2014;13(4):711-23. doi: 10.1187/cbe.13-10-0200.

In their 2012 report, the President's Council of Advisors on Science and Technology advocated "replacing standard science laboratory courses with discovery-based research courses"-a challenging proposition that presents practical and pedagogical difficulties. In this paper, we describe our collective experiences...

Cite
Lopatto D, Hauser C, Jones CJ, et al. A central support system can facilitate implementation and sustainability of a Classroom-based Undergraduate Research Experience (CURE) in Genomics. CBE Life Sci Educ. 2014;13(4):711-23doi: 10.1187/cbe.13-10-0200.
Lopatto, D., Hauser, C., Jones, C. J., Paetkau, D., Chandrasekaran, V., Dunbar, D., MacKinnon, C., Stamm, J., Alvarez, C., Barnard, D., Bedard, J. E., Bednarski, A. E., Bhalla, S., Braverman, J. M., Burg, M., Chung, H. M., DeJong, R. J., DiAngelo, J. R., Du, C., Eckdahl, T. T., Emerson, J., Frary, A., Frohlich, D., Goodman, A. L., Gosser, Y., Govind, S., Haberman, A., Hark, A. T., Hoogewerf, A., Johnson, D., Kadlec, L., Kaehler, M., Key, S. C., Kokan, N. P., Kopp, O. R., Kuleck, G. A., Lopilato, J., Martinez-Cruzado, J. C., McNeil, G., Mel, S., Nagengast, A., Overvoorde, P. J., Parrish, S., Preuss, M. L., Reed, L. D., Regisford, E. G., Revie, D., Robic, S., Roecklien-Canfield, J. A., Rosenwald, A. G., Rubin, M. R., Saville, K., Schroeder, S., Sharif, K. A., Shaw, M., Skuse, G., Smith, C. D., Smith, M., Smith, S. T., Spana, E. P., Spratt, M., Sreenivasan, A., Thompson, J. S., Wawersik, M., Wolyniak, M. J., Youngblom, J., Zhou, L., Buhler, J., Mardis, E., Leung, W., Shaffer, C. D., Threlfall, J., & Elgin, S. C. (2014). A central support system can facilitate implementation and sustainability of a Classroom-based Undergraduate Research Experience (CURE) in Genomics. CBE life sciences education, 13(4), 711-23. https://doi.org/10.1187/cbe.13-10-0200
Lopatto, David, et al. "A central support system can facilitate implementation and sustainability of a Classroom-based Undergraduate Research Experience (CURE) in Genomics." CBE life sciences education vol. 13,4 (2014): 711-23. doi: https://doi.org/10.1187/cbe.13-10-0200
Lopatto D, Hauser C, Jones CJ, Paetkau D, Chandrasekaran V, Dunbar D, MacKinnon C, Stamm J, Alvarez C, Barnard D, Bedard JE, Bednarski AE, Bhalla S, Braverman JM, Burg M, Chung HM, DeJong RJ, DiAngelo JR, Du C, Eckdahl TT, Emerson J, Frary A, Frohlich D, Goodman AL, Gosser Y, Govind S, Haberman A, Hark AT, Hoogewerf A, Johnson D, Kadlec L, Kaehler M, Key SC, Kokan NP, Kopp OR, Kuleck GA, Lopilato J, Martinez-Cruzado JC, McNeil G, Mel S, Nagengast A, Overvoorde PJ, Parrish S, Preuss ML, Reed LD, Regisford EG, Revie D, Robic S, Roecklien-Canfield JA, Rosenwald AG, Rubin MR, Saville K, Schroeder S, Sharif KA, Shaw M, Skuse G, Smith CD, Smith M, Smith ST, Spana EP, Spratt M, Sreenivasan A, Thompson JS, Wawersik M, Wolyniak MJ, Youngblom J, Zhou L, Buhler J, Mardis E, Leung W, Shaffer CD, Threlfall J, Elgin SC. A central support system can facilitate implementation and sustainability of a Classroom-based Undergraduate Research Experience (CURE) in Genomics. CBE Life Sci Educ. 2014;13(4):711-23. doi: 10.1187/cbe.13-10-0200. PMID: 25452493; PMCID: PMC4255357.
Copy Download .nbib Format: NLM
Covered metal stenting for malignant lower biliary stricture with pancreatic duct obstruction: is endoscopic sphincterotomy needed?.

Gastroenterology research and practice

Nakahara K, Okuse C, Suetani K, Michikawa Y, Kobayashi S, Otsubo T, Itoh F.
PMID: 24324486
Gastroenterol Res Pract. 2013;2013:375613. doi: 10.1155/2013/375613. Epub 2013 Nov 12.

Aims. To evaluate the need for endoscopic sphincterotomy (EST) before covered self-expandable metal stent (CSEMS) deployment for malignant lower biliary stricture with pancreatic duct obstruction. Methods. This study included 79 patients who underwent CSEMS deployment for unresectable malignant lower...

Cite
Nakahara K, Okuse C, Suetani K, et al. Covered metal stenting for malignant lower biliary stricture with pancreatic duct obstruction: is endoscopic sphincterotomy needed?. Gastroenterol Res Pract. 2013;2013:375613doi: 10.1155/2013/375613.
Nakahara, K., Okuse, C., Suetani, K., Michikawa, Y., Kobayashi, S., Otsubo, T., & Itoh, F. (2013). Covered metal stenting for malignant lower biliary stricture with pancreatic duct obstruction: is endoscopic sphincterotomy needed?. Gastroenterology research and practice, 2013375613. https://doi.org/10.1155/2013/375613
Nakahara, Kazunari, et al. "Covered metal stenting for malignant lower biliary stricture with pancreatic duct obstruction: is endoscopic sphincterotomy needed?." Gastroenterology research and practice vol. 2013 (2013): 375613. doi: https://doi.org/10.1155/2013/375613
Nakahara K, Okuse C, Suetani K, Michikawa Y, Kobayashi S, Otsubo T, Itoh F. Covered metal stenting for malignant lower biliary stricture with pancreatic duct obstruction: is endoscopic sphincterotomy needed?. Gastroenterol Res Pract. 2013;2013:375613. doi: 10.1155/2013/375613. Epub 2013 Nov 12. PMID: 24324486; PMCID: PMC3845734.
Copy Download .nbib Format: NLM
A Practical Guide to Immunoassay Method Validation.

Frontiers in neurology

Andreasson U, Perret-Liaudet A, van Waalwijk van Doorn LJ, Blennow K, Chiasserini D, Engelborghs S, Fladby T, Genc S, Kruse N, Kuiperij HB, Kulic L, Lewczuk P, Mollenhauer B, Mroczko B, Parnetti L, Vanmechelen E, Verbeek MM, Winblad B, Zetterberg H, Koel-Simmelink M, Teunissen CE.
PMID: 26347708
Front Neurol. 2015 Aug 19;6:179. doi: 10.3389/fneur.2015.00179. eCollection 2015.

Biochemical markers have a central position in the diagnosis and management of patients in clinical medicine, and also in clinical research and drug development, also for brain disorders, such as Alzheimer's disease. The enzyme-linked immunosorbent assay (ELISA) is frequently...

Cite
Andreasson U, Perret-Liaudet A, van Waalwijk van Doorn LJ, et al. A Practical Guide to Immunoassay Method Validation. Front Neurol. 2015;6:179doi: 10.3389/fneur.2015.00179.
Andreasson, U., Perret-Liaudet, A., van Waalwijk van Doorn, L. J., Blennow, K., Chiasserini, D., Engelborghs, S., Fladby, T., Genc, S., Kruse, N., Kuiperij, H. B., Kulic, L., Lewczuk, P., Mollenhauer, B., Mroczko, B., Parnetti, L., Vanmechelen, E., Verbeek, M. M., Winblad, B., Zetterberg, H., Koel-Simmelink, M., & Teunissen, C. E. (2015). A Practical Guide to Immunoassay Method Validation. Frontiers in neurology, 6179. https://doi.org/10.3389/fneur.2015.00179
Andreasson, Ulf, et al. "A Practical Guide to Immunoassay Method Validation." Frontiers in neurology vol. 6 (2015): 179. doi: https://doi.org/10.3389/fneur.2015.00179
Andreasson U, Perret-Liaudet A, van Waalwijk van Doorn LJ, Blennow K, Chiasserini D, Engelborghs S, Fladby T, Genc S, Kruse N, Kuiperij HB, Kulic L, Lewczuk P, Mollenhauer B, Mroczko B, Parnetti L, Vanmechelen E, Verbeek MM, Winblad B, Zetterberg H, Koel-Simmelink M, Teunissen CE. A Practical Guide to Immunoassay Method Validation. Front Neurol. 2015 Aug 19;6:179. doi: 10.3389/fneur.2015.00179. eCollection 2015. PMID: 26347708; PMCID: PMC4541289.
Copy Download .nbib Format: NLM
Phase diagram of URu.

Proceedings of the National Academy of Sciences of the United States of America

Ran S, Jeon I, Pouse N, Breindel AJ, Kanchanavatee N, Huang K, Gallagher A, Chen KW, Graf D, Baumbach RE, Singleton J, Maple MB.
PMID: 28847927
Proc Natl Acad Sci U S A. 2017 Sep 12;114(37):9826-9831. doi: 10.1073/pnas.1710192114. Epub 2017 Aug 28.

Electrical transport measurements were performed on URu

Cite
Ran S, Jeon I, Pouse N, et al. Phase diagram of URu. Proc Natl Acad Sci U S A. 2017;114(37):9826-9831doi: 10.1073/pnas.1710192114.
Ran, S., Jeon, I., Pouse, N., Breindel, A. J., Kanchanavatee, N., Huang, K., Gallagher, A., Chen, K. W., Graf, D., Baumbach, R. E., Singleton, J., & Maple, M. B. (2017). Phase diagram of URu. Proceedings of the National Academy of Sciences of the United States of America, 114(37), 9826-9831. https://doi.org/10.1073/pnas.1710192114
Ran, Sheng, et al. "Phase diagram of URu." Proceedings of the National Academy of Sciences of the United States of America vol. 114,37 (2017): 9826-9831. doi: https://doi.org/10.1073/pnas.1710192114
Ran S, Jeon I, Pouse N, Breindel AJ, Kanchanavatee N, Huang K, Gallagher A, Chen KW, Graf D, Baumbach RE, Singleton J, Maple MB. Phase diagram of URu. Proc Natl Acad Sci U S A. 2017 Sep 12;114(37):9826-9831. doi: 10.1073/pnas.1710192114. Epub 2017 Aug 28. PMID: 28847927; PMCID: PMC5604036.
Copy Download .nbib Format: NLM
A case of complete necrosis of well-differentiated early hepatocellular carcinoma by percutaneous transhepatic portal embolization.

Hepatology research : the official journal of the Japan Society of Hepatology

Suzuki M, Maeyama S, Okuse N, Nishikawa K, Kobayashi Y, Takahashi Y, Okuse C, Osada T, Hayashi T, Yotuyanagi H, Takatori M, Ogata S, Uchikoshi T, Iino S.
PMID: 11804837
Hepatol Res. 2002 Jan;22(1):74-82. doi: 10.1016/s1386-6346(01)00117-6.

The patient was a 49-year-old male under observation for chronic hepatitis B. In July 1997, abdominal ultrasonography showed multiple hyperechoic nodules in the right lobe, the largest with a diameter of 3.5 cm. Abdominal computed tomography did not reveal...

Cite
Suzuki M, Maeyama S, Okuse N, et al. A case of complete necrosis of well-differentiated early hepatocellular carcinoma by percutaneous transhepatic portal embolization. Hepatol Res. 2002;22(1):74-82doi: 10.1016/s1386-6346(01)00117-6.
Suzuki, M., Maeyama, S., Okuse, N., Nishikawa, K., Kobayashi, Y., Takahashi, Y., Okuse, C., Osada, T., Hayashi, T., Yotuyanagi, H., Takatori, M., Ogata, S., Uchikoshi, T., & Iino, S. (2002). A case of complete necrosis of well-differentiated early hepatocellular carcinoma by percutaneous transhepatic portal embolization. Hepatology research : the official journal of the Japan Society of Hepatology, 22(1), 74-82. https://doi.org/10.1016/s1386-6346(01)00117-6
Suzuki, Michihiro, et al. "A case of complete necrosis of well-differentiated early hepatocellular carcinoma by percutaneous transhepatic portal embolization." Hepatology research : the official journal of the Japan Society of Hepatology vol. 22,1 (2002): 74-82. doi: https://doi.org/10.1016/s1386-6346(01)00117-6
Suzuki M, Maeyama S, Okuse N, Nishikawa K, Kobayashi Y, Takahashi Y, Okuse C, Osada T, Hayashi T, Yotuyanagi H, Takatori M, Ogata S, Uchikoshi T, Iino S. A case of complete necrosis of well-differentiated early hepatocellular carcinoma by percutaneous transhepatic portal embolization. Hepatol Res. 2002 Jan;22(1):74-82. doi: 10.1016/s1386-6346(01)00117-6. PMID: 11804837.
Copy Download .nbib Format: NLM
Editorial.

Journal of child psychology and psychiatry, and allied disciplines

Skuse D.
PMID: 11260830
J Child Psychol Psychiatry. 2000 May;41(4):405-406. doi: 10.1017/S0021963000009392.

What makes young people act in antisocial ways? This question is discussed from several different angles in our current issue. Delinquency is not, of course, a new phenomenon: for those interested in reading a chilling account of life in...

Cite
Skuse D. Editorial. J Child Psychol Psychiatry. 2000;41(4):405-406doi: 10.1017/S0021963000009392.
Skuse, D. (2000). Editorial. Journal of child psychology and psychiatry, and allied disciplines, 41(4), 405-406. https://doi.org/10.1017/S0021963000009392
Skuse, David. "Editorial." Journal of child psychology and psychiatry, and allied disciplines vol. 41,4 (2000): 405-406. doi: https://doi.org/10.1017/S0021963000009392
Skuse D. Editorial. J Child Psychol Psychiatry. 2000 May;41(4):405-406. doi: 10.1017/S0021963000009392. PMID: 11260830.
Copy Download .nbib Format: NLM
C2H2 interaction with Ni nanocrystals: towards a better understanding of carbon nanotubes nucleation in CVD synthesis.

Ultramicroscopy

Moors M, Visart de Bocarmé T, Kruse N.
PMID: 18995966
Ultramicroscopy. 2009 Apr;109(5):381-4. doi: 10.1016/j.ultramic.2008.09.003. Epub 2008 Sep 26.

We present a study of the early stages of carbon nanotubes nucleation in CVD synthesis by combining field ion/electron emission microscopy (FIM/FEM) and atom-probe investigation (AP) of the nickel-carbon interaction. Acetylene decomposition on Ni tips at 873K is observed...

Cite
Moors M, Visart de Bocarmé T, Kruse N. C2H2 interaction with Ni nanocrystals: towards a better understanding of carbon nanotubes nucleation in CVD synthesis. Ultramicroscopy. 2008;109(5):381-4doi: 10.1016/j.ultramic.2008.09.003.
Moors, M., Visart de Bocarmé, T., & Kruse, N. (2009). C2H2 interaction with Ni nanocrystals: towards a better understanding of carbon nanotubes nucleation in CVD synthesis. Ultramicroscopy, 109(5), 381-4. https://doi.org/10.1016/j.ultramic.2008.09.003
Moors, M, et al. "C2H2 interaction with Ni nanocrystals: towards a better understanding of carbon nanotubes nucleation in CVD synthesis." Ultramicroscopy vol. 109,5 (2009): 381-4. doi: https://doi.org/10.1016/j.ultramic.2008.09.003
Moors M, Visart de Bocarmé T, Kruse N. C2H2 interaction with Ni nanocrystals: towards a better understanding of carbon nanotubes nucleation in CVD synthesis. Ultramicroscopy. 2009 Apr;109(5):381-4. doi: 10.1016/j.ultramic.2008.09.003. Epub 2008 Sep 26. PMID: 18995966.
Copy Download .nbib Format: NLM
Effect of treatment with interferon alpha-2b and ribavirin in patients infected with genotype 2 hepatitis C virus.

Hepatology research : the official journal of the Japan Society of Hepatology

Nagase Y, Yotsuyanagi H, Okuse C, Yasuda K, Kato T, Koike K, Suzuki M, Nishioka K, Iino S, Itoh F.
PMID: 17825061
Hepatol Res. 2008 Mar;38(3):252-8. doi: 10.1111/j.1872-034X.2007.00257.x. Epub 2007 Sep 06.

AIM: Nearly 20% of chronic hepatitis C (CHC) patients with genotype 2 hepatitis C virus (HCV) infection are not curable, even by interferon (IFN)-ribavirin combination therapy. The aim of this study is to investigate the factors that determine the...

Cite
Nagase Y, Yotsuyanagi H, Okuse C, et al. Effect of treatment with interferon alpha-2b and ribavirin in patients infected with genotype 2 hepatitis C virus. Hepatol Res. 2007;38(3):252-8doi: 10.1111/j.1872-034X.2007.00257.x.
Nagase, Y., Yotsuyanagi, H., Okuse, C., Yasuda, K., Kato, T., Koike, K., Suzuki, M., Nishioka, K., Iino, S., & Itoh, F. (2008). Effect of treatment with interferon alpha-2b and ribavirin in patients infected with genotype 2 hepatitis C virus. Hepatology research : the official journal of the Japan Society of Hepatology, 38(3), 252-8. https://doi.org/10.1111/j.1872-034X.2007.00257.x
Nagase, Yoshihiko, et al. "Effect of treatment with interferon alpha-2b and ribavirin in patients infected with genotype 2 hepatitis C virus." Hepatology research : the official journal of the Japan Society of Hepatology vol. 38,3 (2008): 252-8. doi: https://doi.org/10.1111/j.1872-034X.2007.00257.x
Nagase Y, Yotsuyanagi H, Okuse C, Yasuda K, Kato T, Koike K, Suzuki M, Nishioka K, Iino S, Itoh F. Effect of treatment with interferon alpha-2b and ribavirin in patients infected with genotype 2 hepatitis C virus. Hepatol Res. 2008 Mar;38(3):252-8. doi: 10.1111/j.1872-034X.2007.00257.x. Epub 2007 Sep 06. PMID: 17825061.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 228 entries